1/1

Export Ready

ABEVMY 400 MG (BEVACIZUMAB INJECTION)

Name: ABEVMY 400 MG (BEVACIZUMAB INJECTION)
SKU: 8416376
Price: 102.02 USD
Availability: InStock

Sold by Trigen Enterprises · Distributor, Exporter, Importer, Wholesaler · Mumbai, Maharashtra, India

Price

₹ 102.02 /Centimetre

In stock

MRP ~~₹ 398.12~~

Inclusive of all taxes

You Save: ₹ 296.10

Minimum order: 1 Centimetre

Export Snapshot

MOQ

1 Centimetre

Lead time

On request

Packaging

Single vial per pack, sterile

Shelf life / longevity

As per product specification

HSN Code

30021500

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for Trigen Enterprises.

Suitable for

Importers · Distributors · Wholesalers

Mumbai Dispatch on request Verified seller

Trigen Enterprises

Distributor, Exporter, Importer, Wholesaler · Mumbai, Maharashtra, India

Trigen Enterprises is a reputable pharmaceutical distributor based in Mumbai, operating since 2014. As authorized distributors and stockists for leading pharmaceutical companies such as Reliance Life Science, Mylan, Biocon, and Hetero Trigen Enterprises specializes in the oncology segment, offering high-quality products to healthcare providers. The company also engages in government tenders, including IHNS Ashvini, ensuring the availability of essential medications across sectors

Registered address: Mumbai, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

View profile All products

Established

2014

Employees

1–10

GST

27AJVPG8610J1ZQ

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Oct 2024

Turnover

$1 MM - $2 MM

Incorporation Type

On request

Certifications & Awards

Product details

What are the specifications of this product?

Overview

ABEVMY 400 MG is a Bevacizumab injection specifically formulated for targeted cancer therapy. Bevacizumab is a monoclonal antibody that inhibits vascular endothelial growth factor A (VEGF-A), which is essential in tumor angiogenesis, thereby helping to restrict tumor growth by preventing the formation of new blood vessels. This 400 mg injectable solution is intended for intravenous administration under strict medical supervision. It is widely used in various oncological treatments, including colorectal cancer, lung cancer, glioblastoma, and renal cell carcinoma. ABEVMY ensures high purity, efficacy, and bioavailability, making it a reliable therapeutic option for hospitals, oncology clinics, and healthcare providers seeking advanced biologic treatments for cancer management.

Product Description

Description provided by Trigen Enterprises.

Specifications

Dosage Strength	400 mg per vial
Volume	Multiple concentration vials - typically 16 ml / vial
Type of Product	Biologic monoclonal antibody injection
Manufacturer	Specified by seller
Packaging	Single vial per pack, sterile
Storage Temperature	2-8 degrees Celsius
Compliance Standards	Manufactured under GMP and regulatory norms
Mode of Action	Inhibits tumor angiogenesis via VEGF blockade
Intended Use	Oncology therapeutic agent
Route of Administration	Intravenous

Use cases

Category	Pharmaceuticals > Oncology Drugs > Targeted Therapy Drugs > Bevacizumab Injection
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	Single vial per pack, sterile
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Centimetre
Lead time	On request
Payment terms	As per negotiated commercial agreement.

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing ABEVMY 400 MG (BEVACIZUMAB INJECTION). Answers compiled from verified sellers' commercial terms and platform data.

Q: Is ABEVMY 400 MG suitable for treatment of all cancers?

A: ABEVMY 400 MG is specifically approved and effective for certain cancers such as colorectal, lung, glioblastoma, and renal cell carcinoma. Its use should be directed by an oncology specialist depending on the cancer type.

Q: What are the storage requirements for ABEVMY 400 MG injection?

A: ABEVMY 400 MG should be stored refrigerated at 2°C to 8°C and protected from light to maintain stability and efficacy.

Q: Can ABEVMY 400 MG be administered subcutaneously or only intravenously?

A: ABEVMY 400 MG must be administered exclusively via intravenous infusion under medical supervision to ensure safety and efficacy.

Q: What certifications are required for selling ABEVMY 400 MG in India?

A: ABEVMY 400 MG requires certification such as CDSCO approval and compliance with drug scheduling and import regulations under Indian pharmaceutical laws.

Q: Is ABEVMY 400 MG a biosimilar or original biologic product?

A: ABEVMY 400 MG may be a biosimilar version of Bevacizumab and must meet stringent quality and regulatory standards equivalent to the original biologic for therapeutic use.

Question not answered? Ask sellers directly — typical response within 4 hours.